Eastman Chemical (EMN)
(Delayed Data from NYSE)
$100.29 USD
-2.08 (-2.03%)
Updated Sep 3, 2024 04:00 PM ET
After-Market: $99.11 -1.18 (-1.18%) 7:14 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Eastman Chemical (EMN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$111.76 | $128.00 | $78.00 | 9.17% |
Price Target
Based on short-term price targets offered by 17 analysts, the average price target for Eastman Chemical comes to $111.76. The forecasts range from a low of $78.00 to a high of $128.00. The average price target represents an increase of 9.17% from the last closing price of $102.37.
Analyst Price Targets (17)
Broker Rating
Eastman Chemical currently has an average brokerage recommendation (ABR) of 1.97 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms. The current ABR compares to an ABR of 1.97 a month ago based on 17 recommendations.
Of the 17 recommendations deriving the current ABR, eight are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 47.06% and 5.88% of all recommendations. A month ago, Strong Buy made up 47.06%, while Buy represented 5.88%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/EMN.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 8 | 9 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 8 | 8 | 8 | 8 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.97 | 1.97 | 1.97 | 1.97 | 1.92 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/30/2024 | Not Identified | Not Identified | Hold | Hold |
7/30/2024 | Piper Sandler | Charles N Neivert | Hold | Hold |
7/29/2024 | Wells Fargo Securities | Michael J Sison | Hold | Hold |
7/29/2024 | Goldman Sachs | Duffy Fischer | Hold | Hold |
7/29/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/25/2024 | Mizuho SecuritiesUSA | John Roberts | Hold | Hold |
5/23/2024 | UBS | Joshua Spector | Hold | Strong Buy |
5/16/2024 | Evercore Partners | Stephen Richardson | Not Available | Hold |
5/6/2024 | Not Identified | Not Identified | Hold | Hold |
4/9/2024 | KeyBanc Capital Markets | Aleksey Yefremov | Strong Buy | Strong Buy |
2/15/2024 | Atlantic Equities | Colin A Isaac | Not Available | Strong Buy |
12/15/2023 | Tudor Pickering Holt & Co. | Matthew Blair | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.97 |
ABR (Last week) | 1.97 |
# of Recs in ABR | 17 |
Average Target Price | $111.76 |
LT Growth Rate | 17.20% |
Industry | Chemical - Diversified |
Industry Rank by ABR | 230 of 253 |
Current Quarter EPS Est: | 2.12 |